Myopathy associated with severe SARS-CoV-2 infection

Neurologia (Engl Ed). 2020 Nov-Dec;35(9):706-708. doi: 10.1016/j.nrl.2020.07.003. Epub 2020 Jul 21.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Azithromycin / therapeutic use
  • COVID-19 / diagnosis
  • COVID-19 / physiopathology*
  • COVID-19 Drug Treatment
  • Ceftriaxone / therapeutic use
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Middle Aged
  • Muscular Diseases / physiopathology
  • Muscular Diseases / virology*
  • Myalgia / physiopathology
  • Myalgia / virology
  • Pandemics
  • SARS-CoV-2 / drug effects

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Humanized
  • Hydroxychloroquine
  • Ceftriaxone
  • Azithromycin
  • tocilizumab